2012
Resultado de búsqueda
8 de jun. de 2018 · Introduction. Alan Tall has evidence of his first successful experiment—an image of his aunt pulling glass shards out of the backside of his cousin, hit when fleeing the explosion.
The Tall laboratory is conducting research on the pathogenesis of metabolic diseases including atherosclerosis, obesity and fatty liver. A major focus has been on the effects of deleting ATP binding cassette transporters ABCA1 and ABCG1 in specific cell types.
El doctor y profesor Alan Tall, experto mundial en colesterol, explica las últimas investigaciones para acabar con este factor de riesgo que afecta a millones de personas. Dos nuevos medicamentos en pastillas y otro en inyección que reducen el colesterol malo y aumentan el bueno, y una inyección que disminuye los niveles de LDL.
Alan R Tall. Medicine, Columbia University. Verified email at cumc.columbia.edu. medicine atherosclerosis lipoproteins. Articles Cited by Public access. ... F Matsuura, AR Tall. Proceedings of the National Academy of Sciences 101 (26), 9774-9779, 2004. 1307: 2004: Plasma cholesteryl ester transfer protein. AR Tall. Journal of lipid research 34 ...
30 de oct. de 2012 · El colesterol es el malo de la película en las enfermedades cardiovasculares. Sin embargo, Alan Tall apuesta por un enfoque terapéutico basado en potenciar el llamado colesterol bueno o HDL. En su visita a Madrid, el experto ha destacado que una de las asignaturas pendientes de los españoles sigue siendo la prevención.
Contributors: Alan R. Tall; Karin E. Bornfeldt Show more detail. Source: check_circle. Crossref AIMing 2 treat atherosclerosis. Nature Reviews Cardiology 2022-09 | Journal article DOI: 10.1038/s41569-022-00755-0 Contributors ...
Alan R Tall, MD is a professor of medicine and professor of physiology and cellular biophysics at Vagelos College of Physicians and Surgeons. He is also the Tilden-Weger-Bieler Professor of Medicine at NewYork-Presbyterian / Columbia University Irving Medical Center. He is a pulmonologist and an expert in molecular mechanisms of human diseases, such as cholesterol efflux, transcription factors, and macrophage activation.
